
Gilimac PM 2mg/500mg/15mg Tablet SR
Marketer
Pride Healthcare
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Gilimac PM 2mg/500mg/15mg Tablet SR
Diabetic patients can manage their blood glucose with Gilimac PM 2mg/500mg/15mg SR tablets, a combined medication. This extended-release formulation, used alongside diet and exercise, improves glycemic control in adults with type 2 diabetes. It enhances insulin effectiveness, reducing blood sugar. Always follow your physician's prescribed dosage and duration; take it with food to minimize gastrointestinal discomfort. If a dose is missed, take it immediately unless the next dose is imminent; then omit the missed dose and resume the regular schedule. Never double the dose; overdose can cause hypoglycemia. Concomitant use with other antidiabetic medications, alcohol, or skipped meals elevates the risk of hypoglycemia; regular blood glucose monitoring is crucial. Common adverse events include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, disclose any kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals should seek medical consultation. Kidney function tests will be performed before treatment initiation. Limit alcohol consumption, as it may exacerbate side effects.
Uses of Gilimac PM 2mg/500mg/15mg Tablet SR
Managing type 2 diabetes
Major Benefits of Gilimac PM 2mg/500mg/15mg Tablet SR:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the entire tablet without chewing, crushing, or breaking it. Gilimac PM 2mg/500mg/15mg Extended-Release Tablets should be administered with food.
Common Side effects of Gilimac PM 2mg/500mg/15mg Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Gilimac PM 2mg/500mg/15mg Tablet SR:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the entire tablet without chewing, crushing, or fracturing. Consume Gilimac PM 2mg/500mg/15mg Extended-Release Tablets with food.
How Gilimac PM 2mg/500mg/15mg Tablet SR works:
Gilimac PM 2mg/500mg/15mg Extended-Release Tablets contain glimepiride, metformin, and pioglitazone—three antidiabetic agents with complementary actions. This triple combination improves blood glucose management when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity. Pioglitazone, a thiazolidinedione, further amplifies insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Gilimac PM 2mg/500mg/15mg SR tablets with alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
The use of Gilimac PM 2mg/500mg/15mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any risks before prescribing this medication. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Gilimac PM 2mg/500mg/15mg tablet is likely unsuitable for breastfeeding mothers. Preliminary evidence in humans indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should use Gilimac PM 2mg/500mg/15mg SR tablets cautiously, potentially requiring dosage modification. Physician consultation is essential. For those with severe kidney disease, Gilimac PM 2mg/500mg/15mg SR tablets are contraindicated. Routine kidney function monitoring is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Gilimac PM 2mg/500mg/15mg SR tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. Gilimac PM 2mg/500mg/15mg SR tablets are contraindicated in patients exhibiting severe hepatic dysfunction.
What if you forget to take Gilimac PM 2mg/500mg/15mg Tablet SR :
Should you forget to take a Gilimac PM 2mg/500mg/15mg Tablet SR, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Gilimac PM 2mg/500mg/15mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Medication |
